Z-0641-2024 Class II Ongoing
FDA device recall Z-0641-2024 was initiated by Becton, Dickinson And Company, BD Biosciences on Oct 25, 2023 and is designated Class II. Reason for recall: In vitro diagnostics product that impacts the quality of cell staining can cause low or dim fluorescence signal, which can lead to potential false negative results and misdiagnosis of hematological… The recall status is ongoing. Affected quantity: 464 Vials.
Recall details
- Product Type
- Devices
- Report Date
- Jan 17, 2024
- Initiation Date
- Oct 25, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 464 Vials
Product description
Reason for recall
Distribution pattern
Worldwide - US Nationwide distribution including in the states of IL, MN, FL, MI, MD, NC, NY, CA, GA, AR, KS, PA, NH, TX, OK, MA, MO, DC, AZ, IN, NJ, TN, WA, VA, CT and the countries of CA, BE, SG, HK, TW, BR, MY, IN, BO, PE, JP, MX, CL, KR, UY, AU.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0641-2024
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026